Cleared Special

K070847 - TRIAL CABLE

K070847 is an FDA 510(k) clearance for TRIAL CABLE, manufactured by Advanced Neuromodulation Systems. The device is a Class 2 Neurology device with product code GZB cleared through the Special 510(k) pathway after a 14-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2007
Decision
14d
Days
Class 2
Risk

K070847 is an FDA 510(k) clearance for the TRIAL CABLE, 3009. Classified as Stimulator, Spinal-cord, Implanted (pain Relief) (product code GZB), Class II - Special Controls.

Submitted by Advanced Neuromodulation Systems (Plano, US). The FDA issued a Cleared decision on April 11, 2007 after a review of 14 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5880 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Advanced Neuromodulation Systems devices

FDA 510(k) Submission Details - K070847

510(k) Number K070847 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 28, 2007
Decision Date April 11, 2007
Days to Decision 14 days
Submission Type Special
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
134d faster than avg
Panel avg: 148d · This submission: 14d
Pathway characteristics
Modification to existing cleared device.

GZB Device Classification - Class 2, Special Controls

Product Code GZB Stimulator, Spinal-cord, Implanted (pain Relief)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5880
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZB Stimulator, Spinal-cord, Implanted (pain Relief)

All 99
Devices cleared under the same product code (GZB) and FDA review panel - the closest regulatory comparables to K070847.
PENTA LEAD KITS, MODELS: 3227-3234
K090907 · Advanced Neuromodulation Systems · Jun 2009
CINCH ANCHOR, MODEL 1194
K081208 · Advanced Neuromodulation Systems · Jul 2008
WIDE SPACED QUATTRODE LEADS
K072462 · Advanced Neuromodulation Systems · Oct 2007
TRIPOLE 8C AND 16C AND EXCLAIM 8 LAMITRODE SERIES LEADS
K063080 · Advanced Neuromodulation Systems · Dec 2006
MODEL 3875 1 X 8 SC TEST STIMULATION LEAD
K062041 · Medtronic, Inc. · Aug 2006
ANS 90 CM AND 110 CM (3100 AND 3200 SERIES) LEAD KIT
K053250 · Advanced Neuromodulation Systems · Dec 2005